Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Canada.
Ther Adv Med Oncol. 2011 Nov;3(1 Suppl):S7-S19. doi: 10.1177/1758834011422556.
c-MET is a receptor tyrosine kinase that, after binding with its ligand, hepatocyte growth factor, activates a wide range of different cellular signaling pathways, including those involved in proliferation, motility, migration and invasion. Although c-MET is important in the control of tissue homeostasis under normal physiological conditions, it has also been found to be aberrantly activated in human cancers via mutation, amplification or protein overexpression. This paper provides an overview of the c-MET signaling pathway, including its role in the development of cancers, and provides a rationale for targeting the pathway as a possible treatment option.
c-MET 是一种受体酪氨酸激酶,与配体肝细胞生长因子结合后,激活广泛的不同细胞信号通路,包括参与增殖、运动性、迁移和侵袭的信号通路。虽然 c-MET 在正常生理条件下控制组织动态平衡中很重要,但已经发现它在人类癌症中通过突变、扩增或蛋白过表达而异常激活。本文概述了 c-MET 信号通路,包括其在癌症发展中的作用,并为作为一种可能的治疗选择靶向该通路提供了理论依据。